The number of lymph nodes removed predicts survival in esophageal cancer: An international study on the impact of extent of surgical resection

Annals of Surgery

Volumn 248, Issue 4, 2008, Pages 549-554

  Peyre, Christian G ^a   Hagen, Jeffrey A ^a   DeMeester, Steven R ^a   Altorki, Nasser K ^b   Ancona, Ermanno ^c   Griffin, S Michael ^d   Hölscher, Arnulf ^e   Lerut, Toni ^f   Law, Simon ^g   Rice, Thomas W ^b   Ruol, Alberto ^c   Van Lanschot, Jan J B ^c   Wong, John ^g   DeMeester, Tom R ^a,h  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF PADOVA   (Italy)

^d ROYAL VICTORIA INFIRMARY   (United Kingdom)

^e UNIVERSITY OF COLOGNE   (Germany)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g UNIVERSITY OF HONG KONG   (Hong Kong)

^h NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; INTERNATIONAL COOPERATION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SQUAMOUS CELL CARCINOMA; SURGICAL APPROACH; SURVIVAL RATE; ASIA; CANCER REGISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; ESOPHAGUS TUMOR; EUROPE; FOLLOW UP; LYMPHADENECTOMY; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NORTH AMERICA; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICS; TIME;

ADENOCARCINOMA; AGED; ASIA; CARCINOMA, SQUAMOUS CELL; CONFIDENCE INTERVALS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NORTH AMERICA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE; TIME FACTORS;

EID: 55449126942     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318188c474     Document Type: Article

References (17)

1. Torek F. The first successful case of resection of the thoracic portion of the esophagus for carcinoma. Surg Gynecol Obstet. 1913;16:614.
2. Grey-Turner G. Carcinoma of the esophagus: the question of its treatment by surgery. Lancet. 1936;18:130-134.
3. Oschner A, DeBakey M. Surgical aspects of carcinoma of the esophagus. J Thorac Surg. 1941;10:401-445.
4. Portale G, Hagen JA, Peters JH, et al. Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg. 2006; 202:588-596.
5. Hagen JA, DeMeester SR, Peters JH, et al. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg. 2001;234:520 -530.
6. Sihvo EI, Luostarinen ME, Salo JA. Fate of patients with adenocarcinoma of the esophagus and the esophagogastric junction: a population- based analysis. Am J Gastroenterol. 2004;99:419-424.
7. Hagen JA, Peters JH, DeMeester TR. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia. J Thorac Cardiovasc Surg. 1993;106:850-858.
8. Altorki NK, Girardi L, Skinner DB. En bloc esophagectomy improves survival for stage III esophageal cancer. J Thorac Cardiovasc Surg. 1997;114:948-955.
9. Johansson J, DeMeester TR, Hagen JA, et al. En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus. Arch Surg. 2004;139:627-631.
10. Omloo JM, Lagarde SM, Hulscher JB, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007;246:992-1000.
11. Smith DD, Schwarz RR, Schwarz RE. Impact oftotal lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005;23:7114-7124.
12. Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastrointest Surg. 2007;11:1384-1393.
13. Schroder W, Vallbohmer D, Bludau M, et al. The resection of the Azygos vein-necessary or redundant extension of transthoracic esophagectomy? J Gastrointest Surg. 2008;in press.
14. Nigro JJ, Hagen JA, DeMeester TR, et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg. 1999;117:16 -23.
15. Waterman TA, Hagen JA, Peters JH, et al. The prognostic importance of immunohistochemically detected node metastases in resected esopha- geal adenocarcinoma. Ann Thorac Surg. 2004;78:1161-1169; discussion 1161-1169.
16. Izbicki JR, Hosch SB, Pichlmeier U, et al. Prognostic value of immu- nohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med. 1997;337:1188 -1894.
17. Rizzetto C, DeMeester SR, Hagen JA, et al. En bloc esophagectomy reduces local recurrence and improves survival compared with transhi- atal resection after neoadjuvant therapy for esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2008;135:1228 -1236.